Myalgic Encephalomyelitis/Chronic Fatigue Syndrome as a Hyper-Regulated Immune System Driven by an Interplay Between Regulatory T Cells and Chronic Human Herpesvirus Infections
暂无分享,去创建一个
[1] Mónica A. Farías,et al. Herpes Simplex Virus Type 1 Infection of the Central Nervous System: Insights Into Proposed Interrelationships With Neurodegenerative Disorders , 2019, Front. Cell. Neurosci..
[2] E. Mignot,et al. Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy , 2018, Proceedings of the National Academy of Sciences.
[3] M. Mehta,et al. Mitochondrial complex III is essential for regulatory T cell suppressive function , 2018, Nature.
[4] T. Harrer,et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) , 2018, Journal of Translational Medicine.
[5] M. Pawlita,et al. Cytomegalovirus (CMV) seroprevalence in the adult population of Germany , 2018, PloS one.
[6] D. Al-Sadeq,et al. Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update , 2018, Front. Oncol..
[7] C. Scheibenbogen,et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease. , 2018, Autoimmunity reviews.
[8] J. Rivas,et al. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) , 2018, Front. Immunol..
[9] S. Hauser,et al. B‐cell Therapy for Multiple Sclerosis: Entering an era , 2018, Annals of neurology.
[10] J. W. Lindsey,et al. Antibodies to the Epstein-Barr virus proteins BFRF3 and BRRF2 cross-react with human proteins , 2017, Journal of Neuroimmunology.
[11] Mark M. Davis,et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients , 2017, Proceedings of the National Academy of Sciences.
[12] U. Reimer,et al. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray , 2017, PloS one.
[13] D. Pierson,et al. Latent virus reactivation in astronauts on the international space station , 2017, npj Microgravity.
[14] L. Nacul,et al. How have selection bias and disease misclassification undermined the validity of myalgic encephalomyelitis/chronic fatigue syndrome studies? , 2017, Journal of health psychology.
[15] D. Levy-bruhl,et al. Seroprevalence of cytomegalovirus infection in France in 2010 , 2017, Epidemiology and Infection.
[16] A. Régnault,et al. Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells , 2017, PloS one.
[17] M. Moschos,et al. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents , 2016, Clinical & experimental ophthalmology.
[18] Raluca Eftimie,et al. Mathematical Models for Immunology: Current State of the Art and Future Research Directions , 2016, Bulletin of mathematical biology.
[19] J. Ng,et al. Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison. , 2016, Asian Pacific journal of allergy and immunology.
[20] L. Sechi,et al. Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease? , 2016, Journal of Neuroimmunology.
[21] A. Palotás,et al. Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome , 2016, Translational Psychiatry.
[22] D. Green,et al. Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis , 2015, Nature Immunology.
[23] Underhill Ra. Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease , 2015 .
[24] M. Buckland,et al. Chronic fatigue syndrome and circulating cytokines: A systematic review , 2015, Brain, Behavior, and Immunity.
[25] Ø. Fluge,et al. B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment , 2015, PloS one.
[26] D. Pierson,et al. Multiple latent viruses reactivate in astronauts during Space Shuttle missions , 2014, Brain, Behavior, and Immunity.
[27] Shalini Sharma,et al. Herpes virus entry mediator (HVEM) modulates proliferation and activation of regulatory T cells following HSV-1 infection. , 2014, Microbes and infection.
[28] M. Berk,et al. The Emerging Role of Autoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/cfs) , 2014, Molecular Neurobiology.
[29] S. Schaffert,et al. The interplay between Epstein–Barr virus and B lymphocytes: implications for infection, immunity, and disease , 2014, Immunologic Research.
[30] N. Unterwalder,et al. Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome , 2014, PloS one.
[31] F. Wang,et al. Development of Virus-Specific CD4+ and CD8+ Regulatory T Cells Induced by Human Herpesvirus 6 Infection , 2013, Journal of Virology.
[32] R. Ribeiro,et al. Mechanisms Underlying CD4+ Treg Immune Regulation in the Adult: From Experiments to Models , 2013, Front. Immunol..
[33] M. Maes,et al. Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics , 2013, BMC Medicine.
[34] E. Waubant,et al. Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review , 2013, PloS one.
[35] Pablo Villoslada,et al. Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity , 2013, BMC Systems Biology.
[36] A. Madrigal,et al. Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy , 2013, Cellular and Molecular Immunology.
[37] B. Clotet,et al. Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome , 2013, Journal of Translational Medicine.
[38] J. Lafaille,et al. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. , 2012, Annual review of immunology.
[39] Michele A. Soltis,et al. Frequency of Epitope-Specific Naive CD4+ T Cells Correlates with Immunodominance in the Human Memory Repertoire , 2012, The Journal of Immunology.
[40] Ø. Fluge,et al. Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study , 2011, PloS one.
[41] Joaquín Goñi,et al. Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis , 2011, BMC Systems Biology.
[42] N. Klimas,et al. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis , 2011, Journal of Translational Medicine.
[43] F. Wang,et al. Human Herpesvirus 6 Suppresses T Cell Proliferation through Induction of Cell Cycle Arrest in Infected Cells in the G2/M Phase , 2011, Journal of Virology.
[44] N. Heveker,et al. Herpes simplex virus type 1-induced FasL expression in human monocytic cells and its implications for cell death, viral replication, and immune evasion. , 2011, Viral immunology.
[45] G. Ginsberg,et al. Disruption of Intestinal CD4+ T Cell Homeostasis Is a Key Marker of Systemic CD4+ T Cell Activation in HIV-Infected Individuals , 2010, The Journal of Immunology.
[46] A. Sant,et al. Understanding the focused CD4 T cell response to antigen and pathogenic organisms , 2009, Immunologic research.
[47] Irun R Cohen,et al. Biomarkers, self-antigens and the immunological homunculus. , 2007, Journal of autoimmunity.
[48] Jorge Carneiro,et al. How Regulatory CD25+CD4+ T Cells Impinge on Tumor Immunobiology: The Differential Response of Tumors to Therapies , 2007, The Journal of Immunology.
[49] N. Frenkel,et al. Human Herpesvirus 6A (HHV-6A) and HHV-6B Alter E2F1/Rb Pathways and E2F1 Localization and Cause Cell Cycle Arrest in Infected T Cells , 2007, Journal of Virology.
[50] Jorge Carneiro,et al. How regulatory CD25(+)CD4(+) T cells impinge on tumor immunobiology? On the existence of two alternative dynamical classes of tumors. , 2007, Journal of theoretical biology.
[51] A. Moosmann,et al. Immunodominance of Lytic Cycle Antigens in Epstein-Barr Virus-Specific CD4+ T Cell Preparations for Therapy , 2007, PloS one.
[52] C. van den Dool,et al. When three is not a crowd: a Crossregulation Model of the dynamics and repertoire selection of regulatory CD4+ T cells , 2007, Immunological reviews.
[53] M. Lederman,et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Nature Medicine.
[54] Daniel Rodríguez‐Pinto. B cells as antigen presenting cells. , 2005, Cellular immunology.
[55] L. Frappier,et al. Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation. , 2005, Cancer research.
[56] T. Nomura,et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. , 2004, International immunology.
[57] V. Levitsky,et al. Capacity of Epstein-Barr virus to infect monocytes and inhibit their development into dendritic cells is affected by the cell type supporting virus replication. , 2004, The Journal of general virology.
[58] H. D. de Melker,et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe , 2004, Sexually Transmitted Infections.
[59] Jorge Carneiro,et al. Tolerance and immunity in a mathematical model of T-cell mediated suppression. , 2003, Journal of theoretical biology.
[60] Jeffrey A. Bluestone,et al. Opinion-regulatory lymphocytes: Natural versus adaptive regulatory T cells , 2003, Nature Reviews Immunology.
[61] V. Rivera,et al. Cross‐reactivity with myelin basic protein and human herpesvirus‐6 in multiple sclerosis , 2003, Annals of neurology.
[62] H. Mcdevitt,et al. Tumor necrosis factor-α regulation of CD4+C25+ T cell levels in NOD mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[63] A. Munnich,et al. Trinucleotide repeat contraction: a pitfall in prenatal diagnosis of myotonic dystrophy , 2001, Journal of medical genetics.
[64] J. Carneiro,et al. Modelling T-cell-mediated suppression dependent on interactions in multicellular conjugates. , 2000, Journal of theoretical biology.
[65] B. Gebhardt. Evidence for antigenic cross-reactivity between herpesvirus and the acetylcholine receptor , 2000, Journal of Neuroimmunology.
[66] P. Pellett,et al. Human herpesvirus 6 , 1997, Clinical microbiology reviews.
[67] Ian Hickie,et al. The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.
[68] I. Cohen,et al. Autoimmunity, microbial immunity and the immunological homunculus. , 1991, Immunology today.
[69] T. Dyrberg,et al. Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. , 1989, The Journal of clinical investigation.
[70] F. Matcham,et al. Fatigue and psychosocial variables in autoimmune rheumatic disease and chronic fatigue syndrome: A cross-sectional comparison. , 2017, Journal of psychosomatic research.
[71] Xiurong Zhao,et al. Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L. , 2016, Molecular immunology.
[72] R. Underhill. Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease. , 2015, Medical hypotheses.
[73] Tarek A-Z K Gaber,et al. Multiple Sclerosis/Chronic Fatigue Syndrome overlap: When two common disorders collide. , 2014, NeuroRehabilitation.
[74] J. Carneiro,et al. Dynamics of Peripheral Regulatory and Effector T Cells Competing for Antigen Presenting Cells , 2011 .
[75] Kara Hunter,et al. Type 1 diabetes genes and pathways shared by humans and NOD mice. , 2005, Journal of autoimmunity.
[76] P. Flor-Henry,et al. Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols , 2003 .
[77] Ray H. Baughman,et al. Supporting Online Material , 2003 .